Literature DB >> 27883986

A model of free-living gait: A factor analysis in Parkinson's disease.

Rosie Morris1, Aodhán Hickey1, Silvia Del Din1, Alan Godfrey1, Sue Lord1, Lynn Rochester2.   

Abstract

INTRODUCTION: Gait is a marker of global health, cognition and falls risk. Gait is complex, comprised of multiple characteristics sensitive to survival, age and pathology. Due to covariance amongst characteristics, conceptual gait models have been established to reduce redundancy and aid interpretation. Previous models have been derived from laboratory gait assessments which are costly in equipment and time. Body-worn monitors (BWM) allow for free-living, low-cost and continuous gait measurement and produce similar covariant gait characteristics. A BWM gait model from both controlled and free-living measurement has not yet been established, limiting utility.
METHODS: 103 control and 67 PD participants completed a controlled laboratory assessment; walking for two minutes around a circuit wearing a BWM. 89 control and 58 PD participants were assessed in free-living, completing normal activities for 7 days wearing a BWM. Fourteen gait characteristics were derived from the BWM, selected according to a previous model. Principle component analysis derived factor loadings of gait characteristics.
RESULTS: Four gait domains were derived for both groups and conditions; pace, rhythm, variability and asymmetry. Domains totalled 84.84% and 88.43% of variance for controlled and 90.00% and 93.03% of variance in free-living environments for control and PD participants respectively. Gait characteristic loading was unambiguous for all characteristics apart from gait variability which demonstrated cross-loading for both groups and environments. The model was highly congruent with the original model.
CONCLUSIONS: The conceptual gait models remained stable using a BWM in controlled and free-living environments. The model became more discrete supporting utility of the gait model for free-living gait.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Free-living; Gait; Parkinson’s disease; Principle component analysis

Mesh:

Year:  2016        PMID: 27883986     DOI: 10.1016/j.gaitpost.2016.11.024

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  19 in total

1.  Quantity and quality of gait and turning in people with multiple sclerosis, Parkinson's disease and matched controls during daily living.

Authors:  Vrutangkumar V Shah; James McNames; Martina Mancini; Patricia Carlson-Kuhta; Rebecca I Spain; John G Nutt; Mahmoud El-Gohary; Carolin Curtze; Fay B Horak
Journal:  J Neurol       Date:  2020-01-11       Impact factor: 4.849

2.  Systematic Review Looking at the Use of Technology to Measure Free-Living Symptom and Activity Outcomes in Parkinson's Disease in the Home or a Home-like Environment.

Authors:  Catherine Morgan; Michal Rolinski; Roisin McNaney; Bennet Jones; Lynn Rochester; Walter Maetzler; Ian Craddock; Alan L Whone
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

3.  Is every-day walking in older adults more analogous to dual-task walking or to usual walking? Elucidating the gaps between gait performance in the lab and during 24/7 monitoring.

Authors:  Inbar Hillel; Eran Gazit; Alice Nieuwboer; Laura Avanzino; Lynn Rochester; Andrea Cereatti; Ugo Della Croce; Marcel Olde Rikkert; Bastiaan R Bloem; Elisa Pelosin; Silvia Del Din; Pieter Ginis; Nir Giladi; Anat Mirelman; Jeffrey M Hausdorff
Journal:  Eur Rev Aging Phys Act       Date:  2019-05-03       Impact factor: 3.878

4.  Potential Markers of Progression in Idiopathic Parkinson's Disease Derived From Assessment of Circular Gait With a Single Body-Fixed-Sensor: A 5 Year Longitudinal Study.

Authors:  M Encarna Micó-Amigo; Idsart Kingma; Sebastian Heinzel; Sietse M Rispens; Tanja Heger; Susanne Nussbaum; Rob C van Lummel; Daniela Berg; Walter Maetzler; Jaap H van Dieën
Journal:  Front Hum Neurosci       Date:  2019-02-19       Impact factor: 3.169

Review 5.  The Role of Movement Analysis in Diagnosing and Monitoring Neurodegenerative Conditions: Insights from Gait and Postural Control.

Authors:  Christopher Buckley; Lisa Alcock; Ríona McArdle; Rana Zia Ur Rehman; Silvia Del Din; Claudia Mazzà; Alison J Yarnall; Lynn Rochester
Journal:  Brain Sci       Date:  2019-02-06

6.  Comparison of gait characteristics between clinical and daily life settings in children with cerebral palsy.

Authors:  Kamiar Aminian; Stéphane Armand; Lena Carcreff; Corinna N Gerber; Anisoara Paraschiv-Ionescu; Geraldo De Coulon; Christopher J Newman
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

7.  Independent and sensitive gait parameters for objective evaluation in knee and hip osteoarthritis using wearable sensors.

Authors:  Ramon J Boekesteijn; José M H Smolders; Vincent J J F Busch; Alexander C H Geurts; Katrijn Smulders
Journal:  BMC Musculoskelet Disord       Date:  2021-03-03       Impact factor: 2.362

8.  A New Method of Evaluating the Symmetry of Movement Used to Assess the Gait of Patients after Unilateral Total Hip Replacement.

Authors:  Slawomir Winiarski; Alicja Rutkowska-Kucharska; Andrzej Pozowski; Krzysztof Aleksandrowicz
Journal:  Appl Bionics Biomech       Date:  2019-12-01       Impact factor: 1.781

Review 9.  The Use of Inertial Measurement Units for the Study of Free Living Environment Activity Assessment: A Literature Review.

Authors:  Sylvain Jung; Mona Michaud; Laurent Oudre; Eric Dorveaux; Louis Gorintin; Nicolas Vayatis; Damien Ricard
Journal:  Sensors (Basel)       Date:  2020-10-01       Impact factor: 3.576

10.  Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study.

Authors:  Thomas Payne; Matilde Sassani; Ellen Buckley; Sarah Moll; Adriana Anton; Matthew Appleby; Seema Maru; Rosie Taylor; Alisdair McNeill; N Hoggard; Claudia Mazza; Iain D Wilkinson; Thomas Jenkins; Thomas Foltynie; O Bandmann
Journal:  BMJ Open       Date:  2020-08-05       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.